Herein, we report the development of an 18F鈥恖abeled, activity鈥恇ased small鈥恗olecule probe targeting the cancer鈥恆ssociated serine hydrolase NCEH1. We undertook a focused medicinal chemistry campaign to simultaneously preserve potent and specific NCEH1 labeling in live cells and animals, while permitting facile 18F radionuclide incorporation required for PET imaging. The resulting molecule, [18F]JW199, labels active NCEH1 in live cells at nanomolar concentrations and greater than 1000鈥恌old selectivity relative to other serine hydrolases. [18F]JW199 displays rapid, NCEH1鈥恉ependent accumulation in mouse tissues. Finally, we demonstrate that [18F]JW199 labels aggressive cancer tumor cells in鈥卾ivo, which uncovered localized NCEH1 activity at the leading edge of triple鈥恘egative breast cancer tumors, suggesting roles for NCEH1 in tumor aggressiveness and metastasis.